Integration of next-generation sequencing into clinical practice: Are we there yet?

Seminars in Oncology

Volumn 39, Issue 1, 2012, Pages 26-36

  Kohlmann, Alexander ^a   Grossmann, Vera ^a   Haferlach, Torsten ^a  

^a MLL MUNICH LEUKEMIA LABORATORY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MOLECULAR MARKER; TRANSCRIPTION FACTOR RUNX1;

ACCURACY; AMPLICON; ARTICLE; BIOLUMINESCENCE; CHRONIC MYELOMONOCYTIC LEUKEMIA; CLINICAL PRACTICE; COMPUTER PROGRAM; DATA ANALYSIS; DATA PROCESSING; DISEASE CLASSIFICATION; DISEASE COURSE; DNA BARCODING; EXON; GENE LIBRARY; GENE MUTATION; GENE SEQUENCE; HAIRY CELL LEUKEMIA; HUMAN; INTEGRATED CIRCUIT; MYELODYSPLASTIC SYNDROME; OVERALL SURVIVAL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PYROSEQUENCING; REPRODUCIBILITY; SENSITIVITY ANALYSIS; SEQUENCE ANALYSIS; THROMBOCYTHEMIA;

HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; LEUKEMIA, MYELOMONOCYTIC, CHRONIC; PROTO-ONCOGENE PROTEINS; SEQUENCE ANALYSIS, DNA;

EID: 84856390048     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2011.11.008     Document Type: Article

References (48)

1. R.K. Thomas, E. Nickerson, J.F. Simons Sensitive mutation detection in heterogeneous cancer specimens by massively parallel picoliter reactor sequencing Nat Med 12 2006 852 855 (Pubitemid 44050078)
2. K.V. Voelkerding, S.A. Dames, J.D. Durtschi Next-generation sequencing: from basic research to diagnostics Clin Chem 55 2009 641 658
3. M.L. Metzker Sequencing technologiesthe next generation Nat Rev Genet 11 2010 31 46
4. T.J. Ley, E.R. Mardis, L. Ding DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome Nature 456 2008 66 72
5. T.J. Ley, L. Ding, M.J. Walter DNMT3A mutations in acute myeloid leukemia N Engl J Med 363 2010 2424 2433
6. E.R. Mardis, L. Ding, D.J. Dooling Recurring mutations found by sequencing an acute myeloid leukemia genome N Engl J Med 361 2009 1058 1066
7. A. Hoischen, B.W. van Bon, C. Gilissen De novo mutations of SETBP1 cause Schinzel-Giedion syndrome Nat Genet 42 2010 483 485
8. L.E. Vissers, J. de Ligt, C. Gilissen A de novo paradigm for mental retardation Nat Genet 42 2010 1109 1112
9. E.R. Mardis, R.K. Wilson Cancer genome sequencing: a review Hum Mol Genet 18 2009 R163 R168
10. Q. Zhao, E.F. Kirkness, O.L. Caballero Systematic detection of putative tumor suppressor genes through the combined use of exome and transcriptome sequencing Genome Biol 11 2010 R114
11. J.K. Teer, L.L. Bonnycastle, P.S. Chines Systematic comparison of three genomic enrichment methods for massively parallel DNA sequencing Genome Res 20 2010 1420 1431
12. T.J. Albert, M.N. Molla, D.M. Muzny Direct selection of human genomic loci by microarray hybridization Nat Methods 4 2007 903 905 (Pubitemid 350042375)
13. A. Gnirke, A. Melnikov, J. Maguire Solution hybrid selection with ultra-long oligonucleotides for massively parallel targeted sequencing Nat Biotechnol 27 2009 182 189
14. V.P. Van, T. Palomero, H. Khiabanian PHF6 mutations in T-cell acute lymphoblastic leukemia Nat Genet 42 2010 338 342
15. V. Grossmann, A. Kohlmann, H.U. Klein Targeted next-generation sequencing detects point mutations, insertions, deletions and balanced chromosomal rearrangements as well as identifies novel leukemia-specific fusion genes in a single procedure Leukemia 25 2011 671 680
16. T. Walsh, M.K. Lee, S. Casadei Detection of inherited mutations for breast and ovarian cancer using genomic capture and massively parallel sequencing Proc Natl Acad Sci U S A 107 2010 12629 12633
17. D. Dressman, H. Yan, G. Traverso, K.W. Kinzler, B. Vogelstein Transforming single DNA molecules into fluorescent magnetic particles for detection and enumeration of genetic variations Proc Natl Acad Sci U S A 100 2003 8817 8822 (Pubitemid 36899181)
18. E.R. Mardis Next-generation DNA sequencing methods Annu Rev Genomics Hum Genet 9 2008 387 402
19. M. Margulies, M. Egholm, W.E. Altman Genome sequencing in microfabricated high-density picolitre reactors Nature 437 2005 376 380 (Pubitemid 41613494)
20. R.K. Thomas, H. Greulich, Y. Yuza Detection of oncogenic mutations in the EGFR gene in lung adenocarcinoma with differential sensitivity to EGFR tyrosine kinase inhibitors Cold Spring Harb Symp Quant Biol 70 2005 73 81 (Pubitemid 44124858)
21. A. Kohlmann, V. Grossmann, H.U. Klein Next-generation sequencing technology reveals a characteristic pattern of molecular mutations in 72.8% of chronic myelomonocytic leukemia by detecting frequent alterations in TET2, CBL, RAS, and RUNX1 J Clin Oncol 28 2010 3858 3865
22. V. Grossmann, S. Schnittger, S. Schindela Strategy for robust detection of insertions, deletions, and point mutations in CEBPA, a GC-rich content gene, using 454 next-generation deep-sequencing technology J Mol Diagn 13 2011 129 136
23. M. Jadersten, L. Saft, A. Smith TP53 mutations in low-risk myelodysplastic syndromes with del(5q) predict disease progression J Clin Oncol 29 2011 1971 1979
24. F. Delhommeau, S. Dupont, V. Della Mutation in TET2 in myeloid cancers N Engl J Med 360 2009 2289 2301
25. M. Ko, Y. Huang, A.M. Jankowska Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2 Nature 468 2010 839 843
26. T. Ernst, A.J. Chase, J. Score Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders Nat Genet 42 2010 722 726
27. G. Nikoloski, S.M. Langemeijer, R.P. Kuiper Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes Nat Genet 42 2010 665 667
28. V. Gelsi-Boyer, V. Trouplin, J. Adelaide Mutations of polycomb-associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemia Br J Haematol 145 2009 788 800
29. Y. Li, G. Bollag, R. Clark Somatic mutations in the neurofibromatosis 1 gene in human tumors Cell 69 1992 275 281
30. R.K. Slany The molecular biology of mixed lineage leukemia Haematologica 94 2009 984 993
31. R. Bejar, K. Stevenson, O. Abdel-Wahab Clinical effect of point mutations in myelodysplastic syndromes N Engl J Med 364 2011 2496 2506
32. E. Tiacci, V. Trifonov, G. Schiavoni BRAF mutations in hairy-cell leukemia N Engl J Med 364 2011 2305 2315
33. T. Zenz, B. Eichhorst, R. Busch TP53 mutation and survival in chronic lymphocytic leukemia J Clin Oncol 28 2010 4473 4479
34. A. Kohlmann, H.U. Klein, S. Weissmann The Interlaboratory RObustness of Next-generation sequencing (IRON) study: a deep sequencing investigation of TET2, CBL and KRAS mutations by an international consortium involving 10 laboratories Leukemia 25 2011 1840 1848
35. K.V. Voelkerding, S. Dames, J.D. Durtschi Next generation sequencing for clinical diagnostics-principles and application to targeted resequencing for hypertrophic cardiomyopathy: a paper from the 2009 William Beaumont Hospital Symposium on Molecular Pathology J Mol Diagn 12 2010 539 551
36. M.M. DeAngelis, D.G. Wang, T.L. Hawkins Solid-phase reversible immobilization for the isolation of PCR products Nucleic Acids Res 23 1995 4742 4743 (Pubitemid 126003282)
37. H.U. Klein, C. Bartenhagen, A. Kohlmann R453Plus1Toolbox: an R/Bioconductor package for analyzing Roche 454 Sequencing data Bioinformatics 27 2011 1162 1163
38. E.W. Sayers, T. Barrett, D.A. Benson Database resources of the National Center for Biotechnology Information Nucleic Acids Res 39 2011 D38 D51
39. S. Datta, S. Datta, S. Kim, S. Chakraborty, R.S. Gill Statistical analyses of next generation sequence data: a partial overview J Proteomics Bioinform 3 2010 183 190
40. C. Hedskog, M. Mild, J. Jernberg Dynamics of HIV-1 quasispecies during antiviral treatment dissected using ultra-deep pyrosequencing PLoS One 5 2010 e11345
41. F. Dicker, C. Haferlach, J. Sundermann Mutation analysis for RUNX1, MLL-PTD, FLT3-ITD, NPM1 and NRAS in 269 patients with MDS or secondary AML Leukemia 24 2010 1528 1532
42. S. Schnittger, F. Dicker, W. Kern RUNX1 mutations are frequent in de novo AML with noncomplex karyotype and confer an unfavorable prognosis Blood 117 2011 2348 2357
43. A. Kohlmann, V. Grossmann, S. Schindela Ultra-deep next-generation sequencing detects RUNX1 mutations with unprecedented sensitivity and allows to monitor minimal residual disease in 116 samples from MDS and AML patients Blood 116 2010 1691a
44. S. Schnittger, U. Bacher, W. Kern, M. Schroder, T. Haferlach, C. Schoch Report on two novel nucleotide exchanges in the JAK2 pseudokinase domain: D620E and E627E Leukemia 20 2006 2195 2197 (Pubitemid 44782853)
45. A.M. Mohamedali, A.E. Smith, J. Gaken Novel TET2 mutations associated with UPD4q24 in myelodysplastic syndrome J Clin Oncol 27 2009 4002 4006
46. A.E. Smith, A.M. Mohamedali, A. Kulasekararaj Next-generation sequencing of the TET2 gene in 355 MDS and CMML patients reveals low-abundance mutant clones with early origins, but indicates no definite prognostic value Blood 116 2010 3923 3932
47. X.S. Puente, M. Pinyol, V. Quesada Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia Nature 475 2011 101 105
48. M.A. Chapman, M.S. Lawrence, J.J. Keats Initial genome sequencing and analysis of multiple myeloma Nature 471 2011 467 472